Loading provider…
Loading provider…
Hematology & Oncology Physician in Cumberland, MD
NPI: 1336137876Primary Practice Location
WESTERN MARYLAND REGIONAL MEDICAL CENTER
12500 Willowbrook Rd, Cumberland, MD
Primary Employer
UPMC Western Maryland Health Services, LLC
upmc.com
HQ Phone
Get MD Blanche's Phone Numberphone_androidMobile
Get MD Blanche's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 329 | 811 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 323 | 405 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 84 | 95 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 57 | 57 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 53 | 57 |
Efficacy of solubilized vemurafenib administered via nasogastric tube.
Authors: Farhad Khimani, Christina Hoban, Vicky Williams, Blanche Mavromatis, Miklos Auber, Jame Abraham, Gerald Higa
Publication Date: 2014-02-05
Authors: Samuel Rubinstein, Jeremy Warner, Karen Russell, Monika Joshi, Howard Zaren, Ulysses Wu, Rahul Nanchal, Melissa Accordino, Matthew Puc, Ryann Quinn, Bryan Faller, Lisa Weissmann, Sunny R K Singh, Toni Choueiri, Praveen Vikas
Journal: Lancet Reg Health Am
Publication Date: 2023-02-13
Authors: Hatem Soliman, Rubina Qamar, Ellis Levine, Raye Budway, Michaela Tsai, Shelly Lo, Pat Whitworth
Journal: JAMA Oncol
Publication Date: 2018-01-11
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Bevacizumab, DRUG: Oxaliplatin, DRUG: Irinotecan, DIETARY_SUPPLEMENT: Cholecalciferol, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Rucaparib